Lipid Metabolic Reprogramming in Hepatocellular Carcinoma.

导出 OA

翻译打印收藏纠错

第一作者： Hayato,Nakagawa

第一单位： Department of Gastroenterology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. hanakagawa-tky@umin.ac.jp.

作者： Hayato,Nakagawa ^[1] ; Yuki,Hayata ^[2] ; Satoshi,Kawamura ^[3] ; Tomoharu,Yamada ^[4] ; Naoto,Fujiwara ^[5] ; Kazuhiko,Koike ^[6]

作者单位： Department of Gastroenterology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. hanakagawa-tky@umin.ac.jp. ^[1] Department of Gastroenterology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. hayatayk728@gmail.com. ^[2] Department of Gastroenterology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. shisato13@gmail.com. ^[3] Department of Gastroenterology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. tyism123@gmail.com. ^[4] Department of Gastroenterology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. fujiwara5358@gmail.com. ^[5] Department of Gastroenterology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. kkoike-tky@umin.ac.jp. ^[6]

关键词 carnitine palmitoyltransferase 2 fatty acid β-oxidation hepatocellular carcinoma metabolic reprogramming non-alcoholic fatty liver disease obesity

DOI 10.3390/cancers10110447

PMID 30445800

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交